BCM
NXTC icon

Bridgeway Capital Management’s NextCure NXTC Stock Holding History

Bridgeway Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,308
Closed -$24.8K – 1233
2025
Q1 		$24.8K Sell
4,308
-1,325
-24% -$11.7K ﹤0.01% 1148
2024
Q4 		$52.1K Sell
5,633
-250
-4% -$3.68K ﹤0.01% 1154
2024
Q3 		$96.7K Hold
5,883
– – ﹤0.01% 1164
2024
Q2 		$112K Hold
5,883
– – ﹤0.01% 1153
2024
Q1 		$157K Sell
5,883
-2,000
-25% -$34.5K ﹤0.01% 1144
2023
Q4 		$108K Hold
7,883
– – ﹤0.01% 1229
2023
Q3 		$122K Hold
7,883
– – ﹤0.01% 1190
2023
Q2 		$170K Hold
7,883
– – ﹤0.01% 1170
2023
Q1 		$140K Sell
7,883
-4,167
-35% -$80.2K ﹤0.01% 1170
2022
Q4 		$204K Buy
12,050
+7,492
+164% +$172K 0.01% 1083
2022
Q3 		$150K Sell
4,558
-5,834
-56% -$297K ﹤0.01% 1196
2022
Q2 		$586K Sell
10,392
-833
-7% -$43.5K 0.01% 846
2022
Q1 		$655K Buy
11,225
+4,167
+59% +$261K 0.01% 876
2021
Q4 		$508K Sell
7,058
-2,500
-26% -$209K 0.01% 980
2021
Q3 		$773K Buy
9,558
+391
+4% +$34.3K 0.01% 904
2021
Q2 		$883K Buy
+9,167
New +$938K 0.02% 904

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return

Bridgeway Capital Management's NXTC Position: Q2 2025 in Review

Bridgeway Capital Management sold out of NextCure (NXTC) in Q2 2025, closing a stake of 4,308 shares — an estimated $24.8K sold.

Bridgeway Capital Management first reported a position in NXTC in Q2 2021 and held it in 16 quarters. The position peaked at $883K in Q2 2021. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2025.

  • Bridgeway Capital Management reported no remaining NextCure position as of Q2 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 4,308 NextCure shares in Q2 2025, an estimated $24.8K.
  • Bridgeway Capital Management first reported a position in NextCure in Q2 2021 and held it in 16 quarters.
  • Bridgeway Capital Management's NextCure position peaked at $883K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held NextCure as of Q2 2025.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.